Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.

Show other versions (1)

BACKGROUND: The question of which antipsychotic drug should be preferred for the treatment of schizophrenia is controversial, and conventional pairwise meta-analyses cannot provide a hierarchy based on the randomised evidence. We aimed to integrate the available evidence to create hierarchies of the...

Full description

Bibliographic Details
Main Authors:	Leucht, S, Cipriani, A, Spineli, L, Mavridis, D, Orey, D, Richter, F, Samara, M, Barbui, C, Engel, R, Geddes, J, Kissling, W, Stapf, M, Lässig, B, Salanti, G, Davis, J
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis
by: Leucht, S, et al.
Published: (2013)

Efficacy of antipsychotic drugs for schizophrenia - Authors' reply.
by: Leucht, S, et al.
Published: (2013)

The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia.
by: Spineli, L, et al.
Published: (2013)

The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia
by: Spineli, L, et al.
Published: (2013)

60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Meta-regression of predictors of placebo response
by: Leucht, S, et al.
Published: (2018)

Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysis
by: Leucht, S, et al.
Published: (2019)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
by: Leucht, S, et al.
Published: (2017)

Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: Systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors.
by: Leucht, S, et al.
Published: (2017)

Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
by: Huhn, M, et al.
Published: (2019)

Initial Severity of Schizophrenia and Efficacy of Antipsychotics: Participant-Level Meta-analysis of 6 Placebo-Controlled Studies.
by: Furukawa, T, et al.
Published: (2015)

New generation versus conventional antipsychotics [3] (multiple letters)
by: Geddes, J, et al.
Published: (2003)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
by: Cipriani, A, et al.
Published: (2009)

Possibly no baseline severity effect for antidepressants versus placebo but for antipsychotics. Why?
by: Leucht, S, et al.
Published: (2018)

Comparative efficacy and tolerability of 31 oral and long-acting injectable antipsychotics for maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis
by: Schneider-Thoma, J, et al.
Published: (2022)

Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis.
by: Spineli, L, et al.
Published: (2013)

Authors' reply
by: Leucht, S, et al.
Published: (2013)

Atypical antipsychotics in the treatment of schizophrenia - Reply
by: Geddes, J, et al.
Published: (2001)

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios.
by: Efthimiou, O, et al.
Published: (2014)

An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios
by: Efthimiou, O, et al.
Published: (2014)

Conventional vs. atypical antipsychotic medications.
by: Barbui, C, et al.
Published: (2006)

Commentary on strategies for switching antipsychotics
by: Leucht Stefan, et al.
Published: (2008-06-01)

Comparison of systematic and narrative reviews: the example of the atypical antipsychotics.
by: Cipriani, A, et al.
Published: (2003)

Do selective serotonin reuptake inhibitors cause suicide? Suicide rate of 15% in editorial is misleading - Reply
by: Cipriani, A, et al.
Published: (2005)

Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey.
by: Barbui, C, et al.
Published: (2013)

Common pitfalls and mistakes in the set-up, analysis and interpretation of results in network meta-analysis: what clinicians should look for in a published article
by: Chaimani, A, et al.
Published: (2017)

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis
by: Cipriani, A, et al.
Published: (2011)

Comparative efficacy and acceptability of antimanic drugs in acute mania: A multiple-treatments meta-analysis
by: Cipriani, A, et al.
Published: (2011)

Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.
by: Cipriani, A, et al.
Published: (2011)

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
by: Geddes, J, et al.
Published: (2000)

Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
by: Maximilian Huhn, et al.
Published: (2022-06-01)

Comparative efficacy of anti-manic drugs in acute mania Reply
by: Cipriani, A, et al.
Published: (2012)

Atypical antipsychotics in the treatment of schizophrenia: Systematic review, meta-regression and evidence-based treatment recommendations
by: Geddes, J, et al.
Published: (2000)

Ranking antidepressants Reply
by: Cipriani, A, et al.
Published: (2009)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia
by: Barber, S, et al.
Published: (2017)

Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review.
by: Mazzucco, S, et al.
Published: (2008)

Efficacy of clozapine compared with other second-generation antipsychotic drugs in patients with treatment-resistant schizophrenia: protocol for a systematic review and individual patient data meta-analysis of randomised controlled trials
by: Georgia Salanti, et al.
Published: (2023-02-01)

Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials
by: Johannes Schneider-Thoma, et al.
Published: (2021-08-01)

Are the results of open randomised controlled trials comparing antipsychotic drugs in schizophrenia biased? Exploratory meta- and subgroup analysis
by: Stefan Leucht, et al.
Published: (2024-02-01)

Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis
by: Miura, T, et al.
Published: (2014)

Network meta-analyses should be the highest level of evidence in treatment guidelines
by: Leucht, S, et al.
Published: (2016)